Overview
Fanggang Ren practices in Taiyuan, China. Ren is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, RUNX1 Familial Platelet Disorder, and Myelodysplastic Syndrome (MDS).
Their clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- LeukemiaRen isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Promyelocytic Leukemia
- Adult T-Cell LeukemiaRen isExperienced. Learn about Adult T-Cell Leukemia.
- Chronic Myelogenous Leukemia (CML)
- Myelodysplastic Syndrome (MDS)
- Myeloproliferative Neoplasms (MPN)